Literature DB >> 28695452

Chronic hepatitis B: correlation of abnormal features on T2-weighted imaging and dynamic contrast-enhanced imaging with hepatic histopathology.

Jian Shu1, Jian Nong Zhao2, Fu Gang Han3, Guang Cai Tang3, Xin Chen3.   

Abstract

OBJECTIVES: To investigate the correlations between abnormal features on liver magnetic resonance (MR) T2-weighted imaging (T2WI) and dynamic contrast-enhanced (DCE) imaging and the pathological findings in chronic hepatitis B.
MATERIALS AND METHODS: Sixty-seven patients with chronic hepatitis B and 18 normal controls who were undergone an abdominal MR imaging were analyzed retrospectively. Patchy hyperintensities, linear and reticular hyperintensities in liver and periportal edema on T2WI and abnormal intrahepatic enhancement signals on DCE imaging were noted. The correlations between the abnormal features detected on hepatic T2WI and DCE imaging, and the levels of inflammatory activity and fibrosis were determined.
RESULTS: Logistic regression analysis showed increased patchy hyperintensities (B = 1.869, P = 0.001) on T2WI and patchy enhancement (B = 1.596, P = 0.004) at the arterial phase along with increased inflammatory activity. However, linear and reticular hyperintensities (B = 2.356, P = 0.000) on T2WI, and meshwork enhancement (B = 2.191, P = 0.000) at the equilibrium phase, all correlated with fibrosis. Moreover, periportal edema mainly correlated with the inflammatory activities (B = 2.635, P = 0.001).
CONCLUSIONS: In chronic hepatitis B patients, patchy hyperintensities on T2WI, periportal edema, and patchy enhancement at the arterial phase can predict moderate-to-severe inflammatory activities, whereas intrahepatic linear and reticular hyperintensities on T2WI, and meshwork enhancement at the equilibrium phase can predict moderate-to-severe fibrosis.

Entities:  

Keywords:  Chronic hepatitis B; Fibrosis; Inflammatory activity; Liver; Magnetic resonance imaging

Mesh:

Substances:

Year:  2017        PMID: 28695452     DOI: 10.1007/s11547-017-0789-8

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  17 in total

Review 1.  Non-invasive assessment of liver fibrosis and prognosis.

Authors:  Michael Hagan; Sumeet K Asrani; Jayant Talwalkar
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015       Impact factor: 3.869

Review 2.  Classification of chronic viral hepatitis: a need for reassessment.

Authors:  P J Scheuer
Journal:  J Hepatol       Date:  1991-11       Impact factor: 25.083

3.  Histological grading and staging in chronic hepatitis: clinical applications and problems.

Authors:  S G Hübscher
Journal:  J Hepatol       Date:  1998-12       Impact factor: 25.083

4.  Chronic hepatitis B: Enlarged perihepatic lymph nodes correlated with hepatic histopathology.

Authors:  Jian Shu; Jian-Nong Zhao; Fu-Gang Han; Guang-Cai Tang; Yin-Deng Luo; Li Luo; Xin Chen
Journal:  World J Radiol       Date:  2013-05-28

5.  Surveillance liver MRI for monitoring patients with known or suspected chronic liver disease.

Authors:  C Pozzessere; K K Porter; I R Kamel
Journal:  Clin Radiol       Date:  2016-09-27       Impact factor: 2.350

6.  Reduced respiratory motion artifacts using structural similarity in fast 2D dynamic contrast enhanced MRI of liver lesions.

Authors:  Edwin E G W Ter Voert; Linda Heijmen; Cornelis J A Punt; Johannes H W de Wilt; Hanneke W M van Laarhoven; Arend Heerschap
Journal:  NMR Biomed       Date:  2016-09-06       Impact factor: 4.044

7.  Periportal high intensity on T2-weighted MR images in acute viral hepatitis.

Authors:  H Itoh; T Sakai; N Takahashi; M Kitada; M Saito; M Kataoka; M Kawamura
Journal:  J Comput Assist Tomogr       Date:  1992 Jul-Aug       Impact factor: 1.826

8.  Oedema of gallbladder wall: correlation with chronic hepatitis B on MR imaging.

Authors:  Jian Shu; Jian Nong Zhao; Fu Gang Han; Guang Cai Tang; Yin Deng Luo; Xin Chen; Li Luo
Journal:  Radiol Med       Date:  2013-05-27       Impact factor: 3.469

9.  Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.

Authors:  Michael Pavlides; Rajarshi Banerjee; Joanne Sellwood; Catherine J Kelly; Matthew D Robson; Jonathan C Booth; Jane Collier; Stefan Neubauer; Eleanor Barnes
Journal:  J Hepatol       Date:  2015-11-10       Impact factor: 25.083

10.  Dynamic contrast-enhanced MRI coupled with a subtraction technique is useful for treatment response evaluation of malignant melanoma hepatic metastasis.

Authors:  Minsu Lee; Song-Ee Baek; Jieun Moon; Yun Ho Roh; Joon Seok Lim; Mi-Suk Park; Myeong-Jin Kim; Honsoul Kim
Journal:  Oncotarget       Date:  2016-06-21
View more
  1 in total

1.  A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study.

Authors:  Zhong-Wei Chen; Huan-Ming Xiao; Xinjian Ye; Kun Liu; Rafael S Rios; Kenneth I Zheng; Yi Jin; Giovanni Targher; Christopher D Byrne; Junping Shi; Zhihan Yan; Xiao-Ling Chi; Ming-Hua Zheng
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.